Mohamed Khairie Issa - 30 Jun 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Role: EVP, Head of US Oncology
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Issuer symbol: INCY
Transactions as of: 30 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2025, 16:42:31 UTC
Previous filing: 08 Jan 2025
Next filing: 17 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Issa Mohamed Khairie	EVP, Head of US Oncology	1801 AUGUSTINE CUT-OFF, WILMINGTON	/s/ Elizabeth Feeney, Attorney-In-Fact	02 Jul 2025	0002050035

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INCY	Common Stock	Award	$0	+27,812	+57%	$0.000000	76,483	30 Jun 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years from the vesting commencement date of January 6, 2025. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2	Including the June 30, 2025 grant, this includes an aggregate of 76,483 shares of common stock issuable pursuant to previously reported RSUs that have not vested.